Shares of drug maker Forest Laboratories Inc. soared Friday, a day after a federal judge upheld a patent for the anti-depressant Lexapro. Judge Joseph J. Farnan of the U.S. District Court in Delaware ruled that the patent on Lexapro was valid and infringed by a generic version proposed by Teva Pharmaceutical Industries Ltd. Forest labs had sued Ivax Corp., which was acquired by Teva this year, when it applied to the Food and Drug Administration to make a generic version of Lexapro.
July 17, 2006 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Shares of drug maker Forest Laboratories Inc. soared Friday, a day after a federal judge upheld a patent for the anti-depressant Lexapro.
Shares of Forest Labs rose $6, or 16 percent, to close at $44.40 on the New York Stock Exchange, near the high end of a 52-week range of $34.54 to $48.51.
Presented by BigVoodoo
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
This conference brings together the industry's most influential & knowledgeable real estate executives from the net lease sector.
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Duane Morris LLP seeks a highly motivated junior associate to join its dynamic and growing Labor and Employment Class Action group in Chicag...
Duane Morris LLP seeks a full-time staff litigation attorney who has practiced between 3-5 years. Experience will include drafting motions, ...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
